Clinical Trial Results: A Study to Learn About the Study Medicine (PF-06823859) in Adults With Active CLE or SLE With Skin Symptoms. [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating PF-06823859 in adults with active cutaneous and systemic lupus erythematosus; study terminated with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lupus Erythematosus Cutaneous
• Lupus Erythematosus Systemic

Drugs mentioned

• PF-06823859

Snippet

Sponsor: Pfizer | Conditions: Lupus Erythematosus, Systemic, Lupus Erythematosus, Cutaneous | Phase 2 | Status: TERMINATED | Results posted: 2026-08-11